inject

Novo Nordisk Inks Insulin Pill Development Pact with Emisphe

Published on Tue, 12/21/2010 - 12:55
By FNN Staff in General Interest, emis, nvo, adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech
adr, diabetes, emis, emisphere, inject, insulin, novo nordsik, nvo, oral, patients, pill, shares, tech

Novo Nordisk (NVO) ADRs are down after the company said it had signed a deal with Emisphere Technologies (EMIS) to use that firm's technology to develop an oral insulin pill, according to a company statement. Currently, there are

By FNN Staff
root@fnn-online.com

Latest News from FNNO

Questar (STR) Approaches New Downside Ta...

Shares of Questar (NYSE:STR) have bearishly opened below the pivot of $25.80 today and ...

Watch for Shares of Total System Service...

Shares of Total System Services (NYSE:TSS) have bearishly opened below the pivot of $24 ...

Waters (WAT) Breaks Through Support at $...

Shares of Waters (NYSE:WAT) opened today below their pivot of $98.23 and have already r ...

Watch for Shares of Rockwell Automation ...

Rockwell Automation (NYSE:ROK) has opened bearishly below the pivot of $90.77 today and ...

Next Support Level for Entergy (ETR) is ...

Shares of Entergy (NYSE:ETR) opened today below their pivot of $70.32 and have already ...

Next Support Level for DENTSPLY Internat...

DENTSPLY International (NASDAQ:XRAY) has opened bearishly below the pivot of $42.24 tod ...

Sealed Air (SEE) Breaks Through Resistan...

Shares of Sealed Air (NYSE:SEE) have bullishly opened above the pivot of $23.81 today a ...

Next Resistance Level for Whirlpool (WHR...

Shares of Whirlpool (NYSE:WHR) opened today above their pivot of $130.34 and have alrea ...

Most Popular Video News